Protective mechanisms of respiratory tract streptococci against Streptococcus pyogenes biofilm formation and epithelial cell infection

Applied and Environmental Microbiology

Volumn 79, Issue 4, 2013, Pages 1265-1276

  Fiedler, Tomas ^a   Riani, Catur ^a,b   Koczan, Dirk ^a   Standar, Kerstin ^a   Kreikemeyer, Bernd ^a   Podbielski, Andreas ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

^b BANDUNG INSTITUTE OF TECHNOLOGY   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

AFFYMETRIX; ARTIFICIAL SALIVA; BACTERIOCINS; BIOFILM FORMATION; BOTTOM LAYERS; CYTOTOXIC EFFECTS; DIRECT CONTACT; ENVIRONMENTAL PROCESS; EPITHELIAL CELLS; HEP-2 CELLS; IN-VITRO; MIXED SPECIES; MOST LIKELY; PROBIOTICS; PROTECTION EFFECT; PROTECTIVE EFFECTS; RESPIRATORY TRACT; STREPTOCOCCUS PYOGENES; TWO-LAYER STRUCTURES; UPPER RESPIRATORY TRACT;

BACTERIA; BIOFILMS; CELLS; CYTOTOXICITY; PHYSIOLOGY; SCANNING ELECTRON MICROSCOPY; STRAIN;

GASES;

BACTERIUM; BIOFILM; BIOME; CELL ORGANELLE; INFECTIVITY; PATHOGEN; PHYSIOLOGICAL RESPONSE; RESPIRATORY DISEASE; SCANNING ELECTRON MICROSCOPY;

ANTIBIOSIS; ARTICLE; BIOFILM; CELL LINE; EPITHELIUM CELL; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; PHYSIOLOGY; RESPIRATORY SYSTEM; SCANNING ELECTRON MICROSCOPY; STREPTOCOCCUS;

ANTIBIOSIS; BIOFILMS; CELL LINE; EPITHELIAL CELLS; HUMANS; MICROSCOPY, ELECTRON, SCANNING; RESPIRATORY SYSTEM; STREPTOCOCCUS;

EID: 84874688825     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.03350-12     Document Type: Article

References (90)

1. Cunningham MW. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470-511.
2. Carapetis JR, Steer AC, Mulholland EK, Weber M. 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5:685-694.
3. Kreikemeyer B, Klenk M, Podbielski A. 2004. The intracellular status of Streptococcus pyogenes: role of extracellular matrix-binding proteins and their regulation. Int. J. Med. Microbiol. 294:177-188.
4. Hynes W. 2004. Virulence factors of the group A streptococci and genes that regulate their expression. Front. Biosci. 9:3399-3433.
5. Olsen RJ, Shelburne SA, Musser JM. 2009. Molecular mechanisms underlying group A streptococcal pathogenesis. Cell Microbiol. 11:1-12.
6. McIver KS. 2009. Stand-alone response regulators controlling global virulence networks in Streptococcus pyogenes. Contrib. Microbiol. 16:103-119.
7. Fiedler T, Sugareva V, Patenge N, Kreikemeyer B. 2010. Insights into Streptococcus pyogenes pathogenesis from transcriptome studies. Future Microbiol. 5:1675-1694.
8. Dmitriev AV, Chaussee MS. 2010. The Streptococcus pyogenes proteome: maps, virulence factors, and vaccine candidates. Future Microbiol. 5:1539-1551.
9. Bessen DE, Lizano S. 2010. Tissue tropisms in group A streptococcal infections. Future Microbiol. 5:623-638.
10. Podbielski A, Kreikemeyer B. 2001. Persistence of group A streptococci in eukaryotic cells: a safe place? Lancet 358:3-4.
11. Österlund A, Engstrand L. 1997. An intracellular sanctuary for Streptococcus pyogenes in human tonsillar epithelium: studies of asymptomatic carriers and in vitro cultured biopsies. Acta Otolaryngol. 117:883-888.
12. Facinelli B, Spinaci C, Magi G, Giovanetti E, Varaldo E. 2001. Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci. Lancet 358:30-33.
13. Reid G. 2005. The importance of guidelines in the development and application of probiotics. Curr. Pharm. Des. 11:11-16.
14. Tagg JR, Dierksen KP. 2003. Bacterial replacement therapy: adapting 'germ warfare' to infection prevention. Trends Biotechnol. 21:217-223.
15. Walls T, Power D, Tagg J. 2003. Bacteriocin-like inhibitory substance (BLIS) production by the normal flora of the nasopharynx: potential to protect against otitis media? J. Med. Microbiol. 52:829-833.
16. Rosenkranz W, Grundmann E. 1994. Immunomodulator action of living, nonpathogenic Enterococcus faecalis bacteria from humans. Arzneimittelforschung 44:691-695. (In German.)
17. Habermann W, Zimmermann K, Skarabis H, Kunze R, Rusch V. 2002. Reduction of acute recurrence in patients with chronic recurrent hypertrophic sinusitis by treatment with a bacterial immunostimulant (Enterococcus faecalis Bacteriae of human origin. Arzneimittelforschung 52:622-627. (In German.)
18. Fiorentino TR, Beall B, Mshar P, Bessen DE. 1997. A genetic-based evaluation of the principal tissue reservoir for group A streptococci isolated from normally sterile sites. J. Infect. Dis. 176:177-182.
19. Moore WE, Moore LV. 1994. The bacteria of periodontal diseases. Periodontol. 2000 5:66-77.
20. Kolenbrander PE. 2000. Oral microbial communities: biofilms, interactions, and genetic systems. Annu. Rev. Microbiol. 54:413-437.
21. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE. 2005. Defining the normal bacterial flora of the oral cavity. J. Clin. Microbiol. 43:5721-5732.
22. Grice EA, Segre JA. 2011. The skin microbiome. Nat. Rev. Microbiol. 9:244-253.
23. Grice EA, Kong HH, Conlan S, Deming CB, Davis J, Young AC, Bouffard GG, Blakesley RW, Murray PR, Green ED, Turner ML, Segre JA. 2009. Topographical and temporal diversity of the human skin microbiome. Science 324:1190-1192.
24. Wade W. 2002. Unculturable bacteria-the uncharacterized organisms that cause oral infections. J. R. Soc. Med. 95:81-83.
25. Parahitiyawa NB, Scully C, Leung WK, Yam WC, Jin LJ, Samaranayake LP. 2010. Exploring the oral bacterial flora: current status and future directions. Oral Dis. 16:136-145.
26. Guglielmetti S, Taverniti V, Minuzzo M, Arioli S, Stuknyte M, Karp M, Mora D. 2010. Oral bacteria as potential probiotics for the pharyngeal mucosa. Appl. Environ. Microbiol. 76:3948-3958.
27. Guglielmetti S, Taverniti V, Minuzzo M, Arioli S, Zanoni I, Stuknyte M, Granucci F, Karp M, Mora D. 2010. A dairy bacterium displays in vitro probiotic properties for the pharyngeal mucosa by antagonizing group A streptococci and modulating the immune response. Infect. Immun. 78:4734-4743.
28. Akiyama H, Morizane S, Yamasaki O, Oono T, Iwatsuki K. 2003. Assessment of Streptococcus pyogenes microcolony formation in infected skin by confocal laser scanning microscopy. J. Dermatol. Sci. 32:193-199.
29. Lembke C, Podbielski A, Hidalgo-Grass C, Jonas L, Hanski E, Kreikemeyer B. 2006. Characterization of biofilm formation by clinically relevant serotypes of group A streptococci. Appl. Environ. Microbiol. 72: 2864-2875.
30. Swidsinski A, Goktas O, Bessler C, Loening-Baucke V, Hale LP, Andree H, Weizenegger M, Holzl M, Scherer H, Lochs H. 2007. Spatial organization of microbiota in quiescent adenoiditis and tonsillitis. J. Clin. Pathol. 60:253-260.
31. Frick IM, Mörgelin M, Björck L. 2000. Virulent aggregates of Streptococcus pyogenes are generated by homophilic protein-protein interactions. Mol. Microbiol. 37:1232-1247.
32. Cho KH, Caparon MG. 2005. Patterns of virulence gene expression differ between biofilm and tissue communities of Streptococcus pyogenes. Mol. Microbiol. 57:1545-1556.
33. Manetti AG, Zingaretti C, Falugi F, Capo S, Bombaci M, Bagnoli F, Gambellini G, Bensi G, Mora M, Edwards AM, Musser JM, Graviss EA, Telford JL, Grandi G, Margarit I. 2007. Streptococcus pyogenes pili promote pharyngeal cell adhesion and biofilm formation. Mol. Microbiol. 64:968-983.
34. Manetti AG, Köller T, Becherelli M, Buccato S, Kreikemeyer B, Podbielski A, Grandi G, Margarit I. 2010. Environmental acidification drives Streptococcus pyogenes pilus expression and microcolony formation on epithelial cells in a FCT-dependent manner. PLoS One 5:e13864. c18.
35. Kimura KR, Nakata M, Sumitomo T, Kreikemeyer B, Podbielski A, Terao Y, Kawabata S. 2012. Involvement of T6 pili in biofilm formation by serotype M6 Streptococcus pyogenes. J. Bacteriol. 194:804-812.
36. Maddocks SE, Wright CJ, Nobbs AH, Brittan JL, Franklin L, Stromberg N, Kadioglu A, Jepson MA, Jenkinson HF. 2011. Streptococcus pyogenes antigen I/II-family polypeptide AspA shows differential ligand-binding properties and mediates biofilm formation. Mol. Microbiol. 81:1034-1049.
37. Podbielski A, Woischnik M, Leonard BA, Schmidt KH. 1999. Characterization of Nra, a global negative regulator gene in group A streptococci. Mol. Microbiol. 31:1051-1064.
38. Cisar JO, Kolenbrander PE, McIntire FC. 1979. Specificity of coaggregation reactions between human oral streptococci and strains of Actinomyces viscosus or Actinomyces naeslundii. Infect. Immun. 24:742-752.
39. Köller T, Manetti AG, Kreikemeyer B, Lembke C, Margarit I, Grandi G, Podbielski A. 2010. Typing of the pilus-protein-encoding FCT region and biofilm formation as novel parameters in epidemiological investigations of Streptococcus pyogenes isolates from various infection sites. J. Med. Microbiol. 59:442-452.
40. Abbott JD, Shannon R. 1958. A method for typing Shigella sonnei, using colicine production as a marker. J. Clin. Pathol. 11:71-77.
41. Molinari G, Rohde M, Talay SR, Chhatwal GS, Beckert S, Podbielski A. 2001. The role played by the group A streptococcal negative regulator Nra on bacterial interactions with epithelial cells. Mol. Microbiol. 40:99-114.
42. Fiedler T, Kreikemeyer B, Sugareva V, Redanz S, Arlt R, Standar K, Podbielski A. 2010. Impact of the Streptococcus pyogenes Mga regulator on human matrix protein binding and interaction with eukaryotic cells. Int. J. Med. Microbiol. 300:248-258.
43. Palmer RJ, Jr, Gordon SM, Cisar JO, Kolenbrander PE. 2003. Coaggregation-mediated interactions of streptococci and actinomyces detected in initial human dental plaque. J. Bacteriol. 185:3400-3409.
44. Amerongen AV, Veerman EC. 2002. Saliva: the defender of the oral cavity. Oral Dis. 8:12-22.
45. Siemens N, Patenge N, Otto J, Fiedler T, Kreikemeyer B. 2011. Streptococcus pyogenes M49 plasminogen/plasmin binding facilitates keratinocyte invasion via integrin-integrin-linked kinase (ILK) pathways and protects from macrophage killing. J. Biol. Chem. 286:21612-21622.
46. Wilson M. 2005. Microbial inhabitants of humans: their ecology and role in health and disease. Cambridge University Press, Cambridge, United Kingdom.
47. Kreth J, Merritt J, Qi F. 2009. Bacterial and host interactions of oral streptococci. DNA Cell Biol. 28:397-403.
48. Rosan B, Lamont RJ. 2000. Dental plaque formation. Microbes. Infect. 2:1599-1607.
49. Wescombe PA, Upton M, Dierksen KP, Ragland NL, Sivabalan S, Wirawan RE, Inglis MA, Moore CJ, Walker GV, Chilcott CN, Jenkinson HF, Tagg JR. 2006. Production of the lantibiotic salivaricin A and its variants by oral streptococci and use of a specific induction assay to detect their presence in human saliva. Appl. Environ. Microbiol. 72:1459-1466.
50. Hyink O, Wescombe PA, Upton M, Ragland N, Burton JP, Tagg JR. 2007. Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K-12. Appl. Environ. Microbiol. 73:1107-1113.
51. Santagati M, Scillato M, Patane F, Aiello C, Stefani S. 2012. Bacteriocinproducing oral streptococci and inhibition of respiratory pathogens. FEMS Immunol. Med. Microbiol. 65:23-31.
52. Birri DJ, Brede DA, Nes IF. 2012. Salivaricin D, a novel intrinsically trypsin-resistant lantibiotic from Streptococcus salivarius 5M6c isolated from a healthy infant. Appl. Environ. Microbiol. 78:402-410.
53. Carlsson J, Grahnen H, Jonsson G, Wikner S. 1970. Early establishment of Streptococcus salivarius in the mouth of infants. J. Dent. Res. 49:415-418.
54. Horz HP, Meinelt A, Houben B, Conrads G. 2007. Distribution and persistence of probiotic Streptococcus salivarius K-12 in the human oral cavity as determined by real-time quantitative polymerase chain reaction. Oral Microbiol. Immunol. 22:126-130.
55. Bernstein JM, Faden HS, Scannapieco F, Belmont M, Dryja D, Wolf J. 2002. Interference of nontypeable Haemophilus influenzae and Moraxella catarrhalis by Streptococcus oralis in adenoid organ culture: a possible strategy for the treatment of the otitis-prone child. Ann. Otol. Rhinol. Laryngol. 111:696-700.
56. Bottone E, Allerhand J, Pisano MA. 1971. Characteristics of a bacteriocin derived from Streptococcus faecalis var. zymogenes antagonistic to Diplococcus pneumoniae. Appl. Microbiol. 22:200-204.
57. Galvez A, Valdivia E, Abriouel H, Camafeita E, Mendez E, Martinez-Bueno M, Maqueda M. 1998. Isolation and characterization of enterocin EJ97, a bacteriocin produced by Enterococcus faecalis EJ97. Arch. Microbiol. 171:59-65.
58. Takemura N, Noiri Y, Ehara A, Kawahara T, Noguchi N, Ebisu S. 2004. Single species biofilm-forming ability of root canal isolates on guttapercha points. Eur. J. Oral Sci. 112:523-529.
59. Baldassarri L, Creti R, Recchia S, Imperi M, Facinelli B, Giovanetti E, Pataracchia M, Alfarone G, Orefici G. 2006. Therapeutic failures of antibiotics used to treat macrolide-susceptible Streptococcus pyogenes infections may be due to biofilm formation. J. Clin. Microbiol. 44:2721-2727.
60. Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg EP. 1998. The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science 280:295-298.
61. Federle MJ, Bassler BL. 2003. Interspecies communication in bacteria. J. Clin. Invest. 112:1291-1299.
62. Stoodley P, Sauer K, Davies DG, Costerton JW. 2002. Biofilms as complex differentiated communities. Annu. Rev. Microbiol. 56:187-209.
63. Suntharalingam P, Cvitkovitch DG. 2005. Quorum sensing in streptococcal biofilm formation. Trends Microbiol. 13:3-6.
64. Li J, Helmerhorst EJ, Leone CW, Troxler RF, Yaskell T, Haffajee AD, Socransky SS, Oppenheim FG. 2004. Identification of early microbial colonizers in human dental biofilm. J. Appl. Microbiol. 97:1311-1318.
65. Sanchez MC, Llama-Palacios A, Blanc V, Leon R, Herrera D, Sanz M. 2011. Structure, viability and bacterial kinetics of an in vitro biofilm model using six bacteria from the subgingival microbiota. J. Periodontal Res. 46:252-260.
66. Murray PA, Levine MJ, Tabak LA, Reddy MS. 1982. Specificity of salivary-bacterial interactions. II. Evidence for a lectin on Streptococcus sanguis with specificity for a NeuAcα2, 3Ga1β1, 3Ga1NAc sequence. Biochem. Biophys. Res. Commun. 106:390-396.
67. Weerkamp AH, McBride BC. 1980. Adherence of Streptococcus salivarius HB and HB-7 to oral surfaces and saliva-coated hydroxyapatite. Infect. Immun. 30:150-158.
68. Hytonen J, Haataja S, Finne J. 2006. Use of flow cytometry for the adhesion analysis of Streptococcus pyogenes mutant strains to epithelial cells: investigation of the possible role of surface pullulanase and cysteine protease, and the transcriptional regulator Rgg.BMCMicrobiol. 6:18.
69. Ryan PA, Pancholi V, Fischetti VA. 2001. Group A streptococci bind to mucin and human pharyngeal cells through sialic acid-containing receptors. Infect. Immun. 69:7402-7412.
70. Shelburne SA, Sumby P, III, Sitkiewicz I, Granville C, Deleo FR, Musser JM. 2005. Central role of a bacterial two-component gene regulatory system of previously unknown function in pathogen persistence in human saliva. Proc. Natl. Acad. Sci. U. S. A. 102:16037-16042.
71. Fernie-King BA, Seilly DJ, Davies A, Lachmann PJ. 2002. Streptococcal inhibitor of complement inhibits two additional components of the mucosal innate immune system: secretory leukocyte proteinase inhibitor and lysozyme. Infect. Immun. 70:4908-4916.
72. Fernie-King BA, Seilly DJ, Lachmann PJ. 2004. The interaction of streptococcal inhibitor of complement (SIC) and its proteolytic fragments with the human beta defensins. Immunology 111:444-452.
73. Frick IM, PÅkesson Rasmussen M, Schmidtchen A, Björck L. 2003. SIC, a secreted protein of Streptococcus pyogenes that inactivates antibacterial peptides. J. Biol. Chem. 278:16561-16566.
74. Shelburne SA, Keith D, III, Horstmann N, Sumby P, Davenport MT, Graviss EA, Brennan RG, Musser JM. 2008. A direct link between carbohydrate utilization and virulence in the major human pathogen groupA Streptococcus. Proc. Natl. Acad. Sci. U. S. A. 105:1698-1703.
75. Shelburne SA, Okorafor N, III, Sitkiewicz I, Sumby P, Keith D, Patel P, Austin C, Graviss EA, Musser JM. 2007. Regulation of polysaccharide utilization contributes to the persistence of group A streptococcus in the oropharynx. Infect. Immun. 75:2981-2990.
76. Courtney HS, Hasty DL. 1991. Aggregation of group A streptococci by human saliva and effect of saliva on streptococcal adherence to host cells. Infect. Immun. 59:1661-1666.
77. Roger P, Delettre J, Bouix M, Beal C. 2011. Characterization of Streptococcus salivarius growth and maintenance in artificial saliva. J. Appl. Microbiol. 111:631-641.
78. Byers HL, Homer KA, Beighton D. 1996. Utilization of sialic acid by viridans streptococci. J. Dent. Res. 75:1564-1571.
79. van der Hoeven JS, van den Kieboom CW, Camp PJ. 1990. Utilization of mucin by oral Streptococcus species. Antonie Van Leeuwenhoek 57:165-172.
80. van der Hoeven JS, Camp PJ. 1991. Synergistic degradation of mucin by Streptococcus oralis and Streptococcus sanguis in mixed chemostat cultures. J. Dent. Res. 70:1041-1044.
81. Dorkhan M, Chavez de Paz LE, Skepo M, Svensater G, Davies JR. 2012. Effects of saliva or serum coating on adherence of Streptococcus oralis strains to titanium. Microbiology 158:390-397.
82. Brook I, Gober AE. 2006. Increased recovery of Moraxella catarrhalis and Haemophilus influenzae in association with group A beta-hemolytic streptococci in healthy children and those with pharyngo-tonsillitis. J. Med. Microbiol. 55:989-992.
83. Lafontaine ER, Wall D, Vanlerberg SL, Donabedian H, Sledjeski DD. 2004. Moraxella catarrhalis coaggregates with Streptococcus pyogenes and modulates interactions of S. pyogenes with human epithelial cells. Infect. Immun. 72:6689-6693.
84. Weerkamp AH, Jacobs T. 1982. Cell wall-associated protein antigens of Streptococcus salivarius: purification, properties, and function in adherence. Infect. Immun. 38:233-242.
85. Weerkamp AH, Handley PS, Baars A, Slot JW. 1986. Negative staining and immunoelectron microscopy of adhesion-deficient mutants of Streptococcus salivarius reveal that the adhesive protein antigens are separate classes of cell surface fibril. J. Bacteriol. 165:746-755.
86. Ishijima SA, Hayama K, Burton JP, Reid G, Okada M, Matsushita Y, Abe S. 2012. Effect of Streptococcus salivarius K-12 on the in vitro growth of Candida albicans and its protective effect in an oral candidiasis model. Appl. Environ. Microbiol. 78:2190-2199.
87. Cosseau C, Devine DA, Dullaghan E, Gardy JL, Chikatamarla A, Gellatly S, Yu LL, Pistolic J, Falsafi R, Tagg J, Hancock RE. 2008. The commensal Streptococcus salivarius K-12 downregulates the innate immune responses of human epithelial cells and promotes host-microbe homeostasis. Infect. Immun. 76:4163-4175.
88. Stinson MW, Alder S, Kumar S. 2003. Invasion and killing of human endothelial cells by viridans group streptococci. Infect. Immun. 71:2365-2372.
89. Hasegawa T, Minami M, Okamoto A, Tatsuno I, Isaka M, Ohta M. 2010. Characterization of a virulence-associated and cell-wall-located DNase of Streptococcus pyogenes. Microbiology 156:184-190.
90. Kaci G, Lakhdari O, Dore J, Ehrlich SD, Renault P, Blottiere HM, Delorme C. 2011. Inhibition of the NF-ΚB pathway in human intestinal epithelial cells by commensal Streptococcus salivarius. Appl. Environ. Microbiol. 77:4681-4684.